Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Real-life management of stage III non-small cell lung cancer patients in Italy: the BE-PACIFIC observational study.
Bironzo P, Morabito A, Silipigni S, Adamo V, Capelletto E, Rossi S, Tiseo M, Montrone M, Facilissimo I, Romano G, Masini LC, Ceresoli GL, Gridelli C, Lugini A, Pilotto S, Tagliaferri P, Bria E, Cortinovis D, Rijavec E, Borghetti P, Brighenti M, Carta AM, Ciuffreda L, Giusti R, Macerelli M, Verderame F, Zanelli F, Berardi R, Gregorc V, Sergi C, Vattemi E, Ferrara R, Piovano PL, Livi L, Borra G, Gori S, Aieta M, Bertolini A, Cecere FL, Pasello G, Rocco D, Certo GL, Marrone L, Simoni L, Roncari B, Novello S, Ramella S; BE-PACIFIC Study Group. Bironzo P, et al. Cancer Treat Res Commun. 2026 Feb 16;47:101143. doi: 10.1016/j.ctarc.2026.101143. Online ahead of print. Cancer Treat Res Commun. 2026. PMID: 41747469
Impact of ECOG performance status 2 participants on outcomes of pivotal cancer clinical trials: a meta-analysis and meta-regression.
Iannantuono GM, Giovagnoli T, Mastrantoni L, Gyawali B, Floudas CS, Sganga S, Giannarelli D, Filetti M, Spinazzola A, Lo Bianco F, Giudice E, Vitale A, Gulley JL, Navarra P, Bria E, Daniele G. Iannantuono GM, et al. Among authors: filetti m. ESMO Open. 2026 Feb;11(2):106065. doi: 10.1016/j.esmoop.2026.106065. Epub 2026 Feb 2. ESMO Open. 2026. PMID: 41633012 Free PMC article.
Performance status eligibility requirements and enrollment characteristics in cancer clinical trials leading to US Food and Drug Administration drugs approval (2009-2023).
Iannantuono GM, Floudas CS, Filetti M, Giovagnoli T, Sganga S, Vitale A, Chandran E, Lombardi P, Rosenfeld R, Giudice E, Xue E, Rapisarda E, Troisi P, Apolo AB, Karzai F, Bria E, Gulley JL, Daniele G. Iannantuono GM, et al. Among authors: filetti m. Eur J Cancer. 2025 Jul 25;225:115589. doi: 10.1016/j.ejca.2025.115589. Epub 2025 Jun 26. Eur J Cancer. 2025. PMID: 40602341 Free PMC article.
Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature.
Filetti M, Occhipinti M, Cirillo A, Scirocchi F, Ugolini A, Giusti R, Lombardi P, Daniele G, Botticelli A, Lo Russo G, De Braud F, Marchetti P, Nuti M, Ferretti E, Farina L, Rughetti A, Petti M. Filetti M, et al. Cancers (Basel). 2024 Nov 26;16(23):3955. doi: 10.3390/cancers16233955. Cancers (Basel). 2024. PMID: 39682144 Free PMC article.
94 results